U.S. COVID-19 vaccine manufacturer Pfizer has faced a grilling in a Senate Estimates hearing in Australia as executives doubled down on the safety of their shot and failed to explain how it causes myocarditis and pericarditis.
On Aug. 3, Pfizer executives appeared before the Education and Employment Legislation Committee, which is investigating the COVID-19 vaccine rollout as part of the Australian Parliamentary inquiry.